Lifecare ASA (OSL:LIFE)

Market Cap	78.53M -57.1%
Revenue (ttm)	6.64M -31.3%
Net Income	-119.53M
EPS	-6.80
Shares Out	191.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,281,830
Average Volume	10,508,642
Open	0.5800
Previous Close	0.6000
Day's Range	0.4110 - 0.6300
52-Week Range	0.3400 - 23.5000
Beta	-0.56
RSI	41.56
Earnings Date	Mar 3, 2026

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 24
• Stock Exchange: Oslo Børs
• Ticker Symbol: LIFE

Financial Performance

In 2025, Lifecare ASA's revenue was 6.64 million, a decrease of -31.34% compared to the previous year's 9.67 million. Losses were -119.53 million, 66.6% more than in 2024.